FilingSEC EDGARPRE 14A
Ensysce Biosciences Files Proxy Materials for Cy Acquisition and PIPE Financing
· SEC accepted
StageAcquisition and Financing
Filing content
Ensysce Biosciences filed proxy materials regarding the acquisition of Cy, involving the issuance of preferred stock and PIPE financing.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…